Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
Conditions
- Locally Advanced Bone Sarcoma
- Locally Advanced Dedifferentiated Liposarcoma
- Locally Advanced Gastrointestinal Stromal Tumor
- Locally Advanced Soft Tissue Sarcoma
- Metastatic Bone Sarcoma
- Metastatic Liposarcoma
- Metastatic Soft Tissue Sarcoma
- Metastatic Undifferentiated Pleomorphic Sarcoma
- Metastatic Unresectable Sarcoma
- Pleomorphic Liposarcoma
- Stage III Bone Sarcoma AJCC v7
- Stage III Soft Tissue Sarcoma AJCC v7
- Stage IV Bone Sarcoma AJCC v7
- Stage IV Soft Tissue Sarcoma AJCC v7
- Stage IVA Bone Sarcoma AJCC v7
- Stage IVB Bone Sarcoma AJCC v7
- Unresectable Bone Sarcoma
- Unresectable Dedifferentiated Liposarcoma
- Unresectable Liposarcoma
- Unresectable Malignant Gastrointestinal Stromal Tumor
- Unresectable Soft Tissue Sarcoma
Interventions
- BIOLOGICAL: Ipilimumab
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Nivolumab
- OTHER: Quality-of-Life Assessment
Sponsor
National Cancer Institute (NCI)